ranolazine has been researched along with ubiquinone in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Iliceto, S; Marangelli, V; Rizzon, P | 1 |
| Hauet, T; Morin, D; Spedding, M; Tillement, J | 1 |
| Amaral, N; Okonko, DO | 1 |
3 review(s) available for ranolazine and ubiquinone
| Article | Year |
|---|---|
Metabolic approach to myocardial ischemia: a novel therapeutic strategy for patients with coronary artery disease?
Topics: Acetanilides; Carnitine; Clinical Trials as Topic; Coenzymes; Coronary Disease; Enzyme Inhibitors; Humans; Myocardial Ischemia; Piperazines; Ranolazine; Superoxide Dismutase; Trimetazidine; Ubiquinone; Vasodilator Agents | 1995 |
Mitochondria as target for antiischemic drugs.
Topics: Acetanilides; Animals; Antioxidants; Coenzymes; Drug Delivery Systems; Enzyme Inhibitors; Humans; Ion Channels; Membrane Proteins; Mitochondria; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Piperazines; Potassium Channels; Ranolazine; Reperfusion Injury; Sodium-Calcium Exchanger; Trimetazidine; Ubiquinone; Vasodilator Agents | 2001 |
Metabolic abnormalities of the heart in type II diabetes.
Topics: Antioxidants; Cardiovascular Agents; Diabetes Mellitus, Type 2; Diabetic Cardiomyopathies; Energy Metabolism; Fatty Acids; Glucose; Humans; Mitochondria, Heart; Myocardium; Organophosphorus Compounds; Oxidative Phosphorylation; Oxidative Stress; Perhexiline; Ranolazine; Trimetazidine; Ubiquinone | 2015 |